- Home
- HST vs RGC Comparison
HST vs RGC Comparison
Compare HST & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HST | RGC |
|---|---|---|
| Founded | 1927 | 2014 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medicinal Chemicals and Botanical Products |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.9B | 9.8B |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | HST | RGC |
|---|---|---|
| Price | $18.25 | $34.13 |
| Analyst Decision | Buy | |
| Analyst Count | 14 | 0 |
| Target Price | ★ $18.54 | N/A |
| AVG Volume (30 Days) | ★ 7.1M | 362.2K |
| Earning Date | 02-18-2026 | 10-24-2025 |
| Dividend Yield | ★ 5.24% | N/A |
| EPS Growth | ★ 3.27 | N/A |
| EPS | ★ 1.06 | N/A |
| Revenue | ★ $5,950,000,000.00 | N/A |
| Revenue This Year | $6.54 | N/A |
| Revenue Next Year | $1.75 | N/A |
| P/E Ratio | $17.12 | ★ N/A |
| Revenue Growth | ★ 6.44 | N/A |
| 52 Week Low | $12.22 | $0.09 |
| 52 Week High | $18.72 | $83.60 |
Technical Indicators
Market Signals| Indicator | HST | RGC |
|---|---|---|
| Relative Strength Index (RSI) | 54.05 | 77.24 |
| Support Level | $17.63 | $20.70 |
| Resistance Level | $18.69 | $25.50 |
| Average True Range (ATR) | 0.34 | 3.55 |
| MACD | -0.07 | 0.91 |
| Stochastic Oscillator | 56.88 | 89.57 |
Price Performance
Historical ComparisonAbout HST Host Hotels & Resorts Inc.
Host Hotels & Resorts owns 80 predominantly urban and resort upper-upscale and luxury hotel properties representing nearly 43,000 rooms, mainly in the United States. Host recently sold off the company's interests in a joint venture owning a portfolio of hotels throughout Europe and also sold other joint ventures that owned properties in Asia and the United States. The majority of Host's portfolio operates under the Marriott and Starwood brands.
About RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.